Categories
Weight Loss Products

Global Weight Loss Dietary Supplements Market during the Forecast Period 2017 – 2026

As per the latest study by Persistence Market Research (PMR), the global weight loss dietary supplements market is anticipated to witness healthy growth. The market is likely to register 6.0% CAGR throughout the forecast period 2017-2026. The global weight loss dietary supplements market is also estimated to bring in US$ 37,177.6 million revenue by 2026 end.

With obesity becoming a global health concern, weight loss continues to be one of the most focused areas. Hence, increasing number of companies are coming up with the new products in weight loss supplements. The increasing consumption and demand for weight loss dietary supplements, regulations on the production of these supplements along with ingredients used are also gaining traction in various countries. The government in various countries are also focusing on the quality and quantity of ingredients used and if any of these ingredients can have severe side-effects, affecting the health of the consumers negatively.

Increasing use of Natural and Organic Ingredients in the Weight Loss Dietary Supplements

The negative effects of being obese and overweight are resulting in the increasing use of weight management products. Consumers are also adopting weight loss supplements in forms of pill, liquid, and powder. Hence, with the increase in the use of these supplements, manufacturers are also trying to produce safer products, thereby using organic and natural ingredients and plant-based ingredients. Among various ingredients, green tea extract is considered as one of the most popular and safest ingredients in the weight loss dietary supplements. Similarly, Garcinia cambogia is also being considered as an ingredient in the weight loss supplements. However, these ingredients have been reported to have adverse effects like a headache, constipation, UTI. Hence, there has been an increase in the investment in the research on other organic ingredients that can be used to produce weight loss supplements.

Global Weight Loss Dietary Supplements Market: Segmental Insights

The global weight loss dietary supplements market includes various segments such as end-user, form, ingredients, distribution channel, and region. Based on the form, the market is categorized into powder, liquid, and soft gell/pills. Soft gell/pills are expected to dominate the market during the forecast period. By the end of 2026, soft gell/pills are expected to exceed US$ 18,500 million revenue.

Based on the end-user, the segment consists of men, women and senior citizen. Among these, women are expected to be the largest users of weight loss dietary supplements. Women segment as the end-user is estimated to create an incremental opportunity of more than US$ 7,900 million between 2017 and 2026.

By Distribution Channel, pharmacies drug store is expected to emerge as the largest distribution channel for the weight loss dietary supplements. Pharmacies drug store is estimated to account for more than one-third of the revenue share by the end of 2017.

A sample of this report is available upon request @  https://www.persistencemarketresearch.com/samples/20380

Based on the ingredients, the segment consists of amino acids, vitamins minerals, botanical supplements, and others. Vitamins minerals are expected to emerge as one of the largest used ingredients in the weight loss dietary supplements. By the end of 2026, vitamins minerals are estimated to exceed US$ 16,900 million revenue.

Region-wise, the market is categorized into Europe, North America, Asia Pacific Excluding Japan (APEJ), Latin America, Japan, and the Middle East and Africa (MEA). Among the given regions, North America is expected to dominate the global weight loss dietary supplements market throughout the forecast period 2017-2026.

Global Weight Loss Dietary Supplements Market: Competitive Assessment

Key players in the global weight loss dietary supplements market are Amway (Nutrilite), Abott Laboratories, GlaxoSmithKline, Glanbia, Herbalife International, Pfizer, American Health, Stepan, Nature’s Sunshine Products, and FANCL.

Categories
Weight Loss Products

Dr. Oz Sued — You Pushed a BS Diet Supplement

Dr. Oz is getting called out again over a “magic weight-loss cure” he touted on his TV show … this time in a class action lawsuit. 

The suit is all over weight loss supplements containing Garcinia Cambogia … which is green coffee bean extract. They’re sold by a company called Labrada, and Dr. Oz covered the products on an episode called “Five Biggest Fat Busters for Five Body Types in Just Five Days.”

The suit, filed by a consumer on behalf of all purchasers, says Oz described Garcinia Cambogia as a revolutionary fat buster which “could be the magic ingredient that lets you lose weight without diet or exercise.” The suit says the “Oz Effect” caused sales to skyrocket.

Oz already had to testify about this product for a Senate panel in 2014, and during the grilling he leaned on evidence from a scientific study. But the lawsuit points out that study has since been discredited.

According to the suit, “all credible scientific evidence” shows Garcinia Cambogia simply doesn’t work. The plaintiffs are going after Oz, Labrada, Harpo Productions and others to get their money back plus damages.

A rep for Oz’s show says the lawsuit attacks his right to free speech and, “As we have always explained to our viewers, the Dr. Oz Show does not sell these products nor does he have any financial ties to these companies.”

Categories
Weight Loss Products

Fake Reviews? How the FTC Got Involved, Reached Settlement

The internet era has enabled millions of consumers to get the inside scoop on merchandise they intend to buy through reading online reviews left by prior purchasers. Many of those reviews were written by legitimate individuals sharing their experience with a particular product or service. However other responses may have been left by trolls or people who have been paid to leave certain types of feedback. Although various review controversies have been covered by the media over the past several years, the FTC has just now settled its first lawsuit regarding fake online reviews.

 

The focus of the FTC’s first successful outcome in cases involving false reviews was a company named Cure Encapsulations, Inc. This organization sells a product called Quality Encapsulations Garcinia Cambogia Extract with HCA. The formulation of that supplement was designed to enable users to lose weight through appetite suppression. The product’s manufacturer also claimed that it could effectively prevent the formation of fat cells. Like many supplements, it was not vetted by the FDA and it is not backed by any scientific testing or results.

 

Despite lacking scientific evidence, the product garnered many positive reviews on internet superstore Amazon. During the FTC’s investigation, it was discovered that many of those positive reviews were purchased from AmazonVerifiedReviews.com. Even before this case, many Amazon consumers have sought to avoid fake reviews by instead visiting websites that provide unbiased reviews including an examination of a product’s pros and cons.

 

Although not the same as prosecution or a lawsuit levied by a federal government agency, Amazon has previously sued firms, including the one used by Cure Encapsulations, for publishing false reviews on their site. Amazon has also investigated significant time and resources in ferreting out false reviews and removing them from their site. At this time, Amazon has blocked Cure Encapsulation from continuing to sell products on their site. The supplement company, which sells a majority of its products as an Amazon third-party retail, may soon find itself in an economically negative situation.

 

The company’s attorney, August Horvath, has pledged to work with Amazon to find an amicable solution. Horvath also says that the company has not solicited or benefitted from fake reviews since the middle of 2015. Nevertheless, the FTC pursued charges of deceptive marketing against the organization, both for fake reviews and making unscientifically based claims as to their product’s efficacy. Terms of the settlement reached have not been released and will likely be subject to non-disclosure agreements.